Tuesday, March 17, 2026

North Korea’s Incomplete Military Capabilities Escalating Global Tension Through Deceptive Diplomatic Solidarity

North Korea's military capabilities are evolving, with a focus on overseas operations and nuclear strategy ahead of the 9th Party Congress.

Google’s New AI Video Tool Lip-Syncs, Talks, and Even Roars

Google unveils Veo 3, an AI video model with sound, alongside Imagen 4 for enhanced image generation at I/O 2025.

MND and MOE Discuss Countermeasures for Inter-Korean Military Talks: “Continued Strengthening of Preparedness”

South Korea aims to enhance military dialogue with North Korea through a new task force and organizational changes, promoting peace by 2026.

Tag: obesity

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

GLP-1 Weight Loss Injections: Are They Causing Gallstone Surge in Asia?

GLP-1 obesity treatments are linked to increased gallstone risk, especially during rapid weight loss, with cases doubling in South Korea.

Novo Nordisk Slashes GLP-1 Drug Prices by Up to 50%: What This Means for Obesity Treatments in 2027

Novo Nordisk will cut prices of GLP-1 treatments in the U.S. by up to 50% from January 2027, amid rising competition and market pressures.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

Chinese Biotech’s Rise: What’s the Standard of Global Tech Trade?

Analysts at the JPMHC noted a shift in biotech, with firms resisting sales and China emerging as a tech transfer leader.

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

Dark Skin Patches in Teens? It Could Be a Warning Sign, Doctors Say

Dark patches on skin folds in adolescents may indicate Acanthosis Nigricans, linked to obesity and insulin resistance. Consult a specialist.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

Underweight People Face Higher Suicide Risk, Study Shows

A study reveals underweight individuals face a higher suicide risk, while overweight individuals show a lower risk, emphasizing BMI's impact.

Study Reveals Semaglutide Reduces Cravings and Helps Control Weight and Blood Sugar

A study shows oral semaglutide aids weight loss and reduces cravings for sugary foods in type 2 diabetes patients.

Could You Have Diabetes? Here’s What You Should Know About the Rising Numbers

In 2022, 14.8% of adults over 30 had diabetes; effective management remains a challenge despite rising awareness and lifestyle changes.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.